BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of iCAD, INC. (“iCAD” or the “Company”) (NASDAQ: ICAD) concerning possible violations of federal securities laws. The investigation focuses on certain statements issued by the Company concerning iCAD’s business and financial prospects.
Please contact Howard G. Smith at (888) 638-4847 or (215) 638-4847, or at firstname.lastname@example.org to discuss this matter. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
iCAD provides image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer in the United States and internationally. Specifically, the investigation relates to the Company’s May 7, 2015 announcement that "Noridian, the Medicare Administrative Contractor in Jurisdictions E and F, which consists of 13 states primarily on the West Coast, has made recent web postings related to Coding for High Dose Rate Brachytherapy for Non-Melanoma Skin Cancers which instruct physicians to report CPT code (17999) rather than the established CPT code (0182T) for electronic brachytherapy for non-melanoma skin cancers. The Company, industry partners and physician providers have reached out to the Centers for Medicare and Medicaid Services (‘CMS’) and Noridian to seek clarification of the Medicare Coverage Articles posted to Noridian's web sites.”
On this news, shares of iCAD fell $3.47 per share, or more than 43%, in intraday trading on May 7, 2015.
If you purchased iCAD shares, if you have information, or would like to learn more about these claims and have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to email@example.com, or visit our website at http://www.howardsmithlaw.com.